**ACA Pharma secures fast-track approval for Eagle Pharmaceuticals' RYANODEX® in Macau; FDA grants accelerated approval to Regeneron's blood cancer drug; Grayscale's ETF conversion halted by SEC despite approval; Mark Zuckerberg asked to leave Oval Office meeting.**